-
1
-
-
0027980918
-
Long-term physical functioning in persons with knee osteoarthritis from NHANESI: Effects of comorbid medical conditions
-
Ettinger W, Davis M, Neurhaus J, et al. Long-term physical functioning in persons with knee osteoarthritis from NHANESI: effects of comorbid medical conditions. J Clin Epidemiol. 1994;47:809-815.
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 809-815
-
-
Ettinger, W.1
Davis, M.2
Neurhaus, J.3
-
2
-
-
0025272082
-
Disorders of the shoulder: An often unrecognised cause of disability in elderly people
-
Chakravarty KK, Webley M. Disorders of the shoulder: an often unrecognised cause of disability in elderly people. Bmj. 1990;300:848-849.
-
(1990)
Bmj
, vol.300
, pp. 848-849
-
-
Chakravarty, K.K.1
Webley, M.2
-
3
-
-
0025835148
-
Shoulder disorders in the elderly: A community survey
-
Chard MD, Hazleman R, Hazleman BL, et al. Shoulder disorders in the elderly: a community survey. Arthritis Rheum. 1991;34:766-769.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 766-769
-
-
Chard, M.D.1
Hazleman, R.2
Hazleman, B.L.3
-
4
-
-
85000257161
-
A comparison of patients with late-stage rheumatoid arthritis and osteoarthritis of the shoulder using self-assessed shoulder function and health status
-
Matsen FA 3rd, Smith KL, DeBartolo SE, et al. A comparison of patients with late-stage rheumatoid arthritis and osteoarthritis of the shoulder using self-assessed shoulder function and health status. Arthritis Care Res. 1997;10:43-47.
-
(1997)
Arthritis Care Res
, vol.10
, pp. 43-47
-
-
Matsen 3rd, F.A.1
Smith, K.L.2
DeBartolo, S.E.3
-
5
-
-
33747151069
-
Long term effects of intra-articular botulinum toxin A for refractory joint pain
-
Mahowald ML, Singh JA, Dykstra D. Long term effects of intra-articular botulinum toxin A for refractory joint pain. Neurotox Res. 2006;9:179-188.
-
(2006)
Neurotox Res
, vol.9
, pp. 179-188
-
-
Mahowald, M.L.1
Singh, J.A.2
Dykstra, D.3
-
6
-
-
0025305554
-
Botulinum toxin injections for cervical dystonia
-
Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990;40:277-280.
-
(1990)
Neurology
, vol.40
, pp. 277-280
-
-
Jankovic, J.1
Schwartz, K.2
-
7
-
-
0011076262
-
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
-
Brin M, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1997;12:722-726.
-
(1997)
Mov Disord
, vol.12
, pp. 722-726
-
-
Brin, M.1
Fahn, S.2
Moskowitz, C.3
-
8
-
-
0033917504
-
Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group
-
Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450.
-
(2000)
Headache
, vol.40
, pp. 445-450
-
-
Silberstein, S.1
Mathew, N.2
Saper, J.3
-
9
-
-
0036559133
-
Botulinum toxin type A (BOTOX) for treatment of migraine
-
Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon. 2002;48:323-335.
-
(2002)
Dis Mon
, vol.48
, pp. 323-335
-
-
Binder, W.J.1
Brin, M.F.2
Blitzer, A.3
-
10
-
-
0035071485
-
Evidence based medicine: Botulinum toxin A in migraine and tension type headache
-
Gobel H, Heinze A, Heinze-Kuhn K, et al. Evidence based medicine: Botulinum toxin A in migraine and tension type headache. J Neurol. 2001; 248:34-38.
-
(2001)
J Neurol
, vol.248
, pp. 34-38
-
-
Gobel, H.1
Heinze, A.2
Heinze-Kuhn, K.3
-
11
-
-
0033975803
-
A comparative trial of botulinum toxin thye A and methylpred-nisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm
-
Porta M. A comparative trial of botulinum toxin thye A and methylpred-nisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000;85:101-105.
-
(2000)
Pain
, vol.85
, pp. 101-105
-
-
Porta, M.1
-
12
-
-
0032143946
-
A randomized, double blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicotho-racic, paraspinal, myofascial pain syndrome
-
Wheeler A, Goolkasian P, Gretz S. A randomized, double blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicotho-racic, paraspinal, myofascial pain syndrome. Spine. 1998;23:1662-1666.
-
(1998)
Spine
, vol.23
, pp. 1662-1666
-
-
Wheeler, A.1
Goolkasian, P.2
Gretz, S.3
-
13
-
-
0036331418
-
Botulinum toxin injection versus surgical treatment for tennis elbow: A randomized pilot study
-
Keizer S, Rutten H, Pilot P, et al. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin Orthop. 2002;401: 125-131.
-
(2002)
Clin Orthop
, vol.401
, pp. 125-131
-
-
Keizer, S.1
Rutten, H.2
Pilot, P.3
-
14
-
-
33747183995
-
Effectivenes of repeated treatment with botulinum toxin type A across different conditions
-
Gordon M, Barron R. Effectivenes of repeated treatment with botulinum toxin type A across different conditions. Southern Med J. 2006;99:853-861.
-
(2006)
Southern Med J
, vol.99
, pp. 853-861
-
-
Gordon, M.1
Barron, R.2
-
15
-
-
0027207199
-
Neglected topics in chronic pain treatment outcome studies: Determination of success
-
Turk DC, Rudy TE, Sorkin BA. Neglected topics in chronic pain treatment outcome studies: determination of success. Pain. 1993;53:3-16.
-
(1993)
Pain
, vol.53
, pp. 3-16
-
-
Turk, D.C.1
Rudy, T.E.2
Sorkin, B.A.3
-
16
-
-
0033991246
-
Sensitivity of embryonic rat dorsal root ganglia neurons to clostriticum botulinum neurotoxins
-
Welch M, Purkiss J, Foster K. Sensitivity of embryonic rat dorsal root ganglia neurons to clostriticum botulinum neurotoxins. Toxicon. 2000;38:245-258.
-
(2000)
Toxicon
, vol.38
, pp. 245-258
-
-
Welch, M.1
Purkiss, J.2
Foster, K.3
-
17
-
-
0034213029
-
Capsicin stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms
-
Purkiss J, Welch M, Doward S, et al. Capsicin stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol. 2000;59:1403-1406.
-
(2000)
Biochem Pharmacol
, vol.59
, pp. 1403-1406
-
-
Purkiss, J.1
Welch, M.2
Doward, S.3
-
18
-
-
0346094286
-
Subcutaneous administration of botuli-num toxin A reduces formalin-induced pain
-
Cui M, Khanijou S, Rubino J, et al. Subcutaneous administration of botuli-num toxin A reduces formalin-induced pain. Pain. 2004;107:125-133.
-
(2004)
Pain
, vol.107
, pp. 125-133
-
-
Cui, M.1
Khanijou, S.2
Rubino, J.3
-
19
-
-
67650325936
-
-
First ER, inventor FIRST, ERIC R, assignee. Application of botulinum toxin to the management of neurogenic inflammatory disorders. US patent 6063768. 2000 2000-05-16
-
First ER, inventor FIRST, ERIC R., assignee. Application of botulinum toxin to the management of neurogenic inflammatory disorders. US patent 6063768. 2000 2000-05-16.
-
-
-
|